BRUKINSA
zanubrutinib
- Strength
- 160 mg/1
- Form
- Tablet, Film Coated
- Class
- Kinase Inhibitor
BeOne Medicines USA, Inc.
Not stocked by us — reference only
zanubrutinib
Listed by BeOne Medicines USA, Inc.
| Dosage form | Capsule |
|---|---|
| Route | Oral |
| Drug class | Kinase Inhibitor |
| Approval route | NDA — original brand approval |
| NDC code | 72579-011 |
| FDA application | NDA213217 |
| RxNorm concept | 2262440 |
| Package sizes listed | 1 |
| Marketed since | November 2019 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
zanubrutinib
BeOne Medicines USA, Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.